|Articles|January 24, 2023
Elligo Adds AI-Driven Clinical Research Study Technology
Introduces new platform which will reduce human error and accelerate trials.
Advertisement
Elligo Health Research® has introduced DataAI Connect, a new data and technology platform that will enable data-driven clinical research. DataAI Connect creates efficiencies across the clinical study workflow—reducing human error and digesting patient data to accelerate clinical trials.
Read more about the new platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Data Strategy, AI Integration, and Rare Disease Milestones Drive Clinical Innovation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
